|
|||||
|
Now Available: CME Opportunity:
|
|||||
Arthritis:
Disease Factors, Corticosteroids Nearly Double Heart Attack Risk in RA Patients
Consumer News:
Bone Loss Stable on Restricted Calorie Diet
BioPharm Business:
Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial of ALO-01 (Embeda) Capsules for Pain Relief in Patients With OA
BioPharm Business:
Centocor's Ustekinumab Demonstrates Superior Efficacy to Enbrel (Etanercept) in Treatment of Moderate-to-Severe Plaque Psoriasis
|
|||||